Background {#Sec1}
==========

Autism spectrum disorders (ASD) are clinically heterogeneous and biologically complex neurobehavioral disorders characterized by social communication deficits, impaired language development, repetitive activities and restrictive range of interests \[[@CR1], [@CR2]\]. In recent years, the incidence of autism has quickly increased; Lai et al. \[[@CR3]\] have reported that the worldwide population prevalence is approximately 1%. Twin studies have suggested that genetic factors are important in the pathogenesis of ASD \[[@CR3]--[@CR5]\]; however, genes associated with ASD pathogenicity still need to be explored.

Microarray technology is a powerful tool used to provide evidence for the genetic contribution to ASD and other complex disorders \[[@CR6]--[@CR11]\]. In recent years, this technology has been applied to detect differentially expressed genes (*DEGs*) between autistic and normal individuals and to explore the pathology of ASD \[[@CR6], [@CR10]--[@CR12]\]. For instance, Voineagu et al. \[[@CR11]\] have further identified discrete modules of co-expressed genes associated with autism, such as the neuronal specific splicing factor *A2BP1*, and have provided evidence implicating transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in ASD. Moreover, this technology has also been used on ASD mouse models and facilitates exploration of the possible molecular mechanisms of ASD \[[@CR13], [@CR14]\]. Finally, some studies have found significantly perturbed pathways in ASD, such as synaptic plasticity \[[@CR13]\], neurogenesis and synaptic activity \[[@CR12]\]. Collectively, these studies based on gene expression analysis can provide clues to guide future research.

Although microarray technology is a strategy to identify associated genes and underlying biological mechanisms, genes identified in one study often are not identified in other studies \[[@CR15]\]. Combining information from multiple reported studies can also improve the reliability and generalizability of results \[[@CR16]\]. Therefore, meta-analysis approaches have been used to identify consistent changes across multiple datasets and have already been successfully applied in different kinds of complex diseases \[[@CR17]--[@CR19]\]. For example, two meta-analyses of ASD \[[@CR20], [@CR21]\] have analyzed data from three human brain studies together with several blood studies and have identified some genes and pathways related to ASD with improved statistical power. Using RNA samples from either peripheral blood or brain tissue, these studies have identified many candidate genes such as *ATP5O, SLC25A12,* and *COX5B* \[[@CR20]\]. However, they have mainly focused on mitochondrial \[[@CR20]\] or ribosomal function \[[@CR21]\], and currently, there is no potential solution for a customized query of meta-analysis results. To solve this problem, we built the database dbMDEGA, a new analytical tool that enables users to query for the statistical and meta-analysis values of a specific gene, and that provides reference datasets for exploring disease biology.

Moreover, another concern in ASD research relates to heterogeneity and tissue diversity such as the differences between blood and brain \[[@CR19]\] and the differences among different regions of the brain \[[@CR11]\]. For ASD studies, the advantage of using blood is that it is easier to collect from patients. However, blood may not be relevant to ASD or neurodevelopmental disorders, which presumably originate in the brain. Then, there may be constitutive differences in gene expression between the blood and brain \[[@CR19], [@CR22]\]. Voineagu et al. \[[@CR11]\] have reported that gene expression changes associated with autism are more pronounced in the cortex. Here, to discover common *DEGs* in ASD with improved statistical power, we applied a systematic meta-analysis to three human brain gene expression datasets \[[@CR6], [@CR11], [@CR23]\] with 84 collective frozen male cortex samples. Moreover, given our ability to visualize the diversity of different brain regions, states and sexes in people with autism compared with unaffected controls; we also collected 53 collective human brain samples (including 17 female cortex samples, 32 cerebellum samples and 4 formalin fixed samples) from three human brain gene expression datasets. Then, we established a database (dbMDEGA) including 17,742 human genes as meta-results for querying *DEGs* in ASD. Furthermore, to support discoveries in human studies, we also collected the current brain gene expression datasets for 14 ASD mouse models \[[@CR24], [@CR25]\] from 80 brain samples in five mouse datasets.

Construction and content {#Sec2}
========================

Data collection {#Sec3}
---------------

We retrieved datasets from Gene Expression Omnibus (GEO) (<http://www.ncbi.nlm.nih.gov/gds>) by using the keyword "autism" on 3 May, 2015. Only expression profiles of brain tissue (cortex and cerebellum) from human ASD studies and mouse ASD models were used in further analysis (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}). Raw expression data generated by the providers for 3 human ASD studies (GEO accession numbers: GSE28475, GSE38322 and GSE28521) and 14 mouse models with ASD-related symptoms (GSE51612, GSE62594, GSE40630, GSE32012, and GSE47150; Table [3](#Tab3){ref-type="table"}) were downloaded. Because the downloadable raw expression data for GSE28475 were already log2 transformed and normalized via quantile normalization with the *lumi* package in R language by the provider, to help ensure comparability and consistency, other raw expression datasets were independently preprocessed through background correction, log2 transformation and quantile normalization or Robust Multiarray Average implemented in the"*lumi* (for Illumina bead chip) \[[@CR26]\]", "*limma* (for Agilent bead chip) \[[@CR27]\]" or "*affy* (for Affymetrix bead chip) \[[@CR28]\]" R package as appropriate (Table [4](#Tab4){ref-type="table"}). Moreover, the downloaded quantile normalization gene expression data for females and for fixed brain tissues in GSE28475 were also log2 transformed to ensure consistency with the meta-analysis data. To ensure comparability and consistency, we excluded 5 female cortex samples that did not meet the criteria (detected gene *p* \< 0.05, outlier detection based on sample distance to "Center", boxplot of microarray intensity) \[[@CR6]\] of GSE28475 according to the reporter. The human brain sample information that was used in our database, after removal of duplicated samples, is shown in Additional file [1](#MOESM1){ref-type="media"}: Table S1 and Additional file [2](#MOESM2){ref-type="media"}: Table S2.Table 1Datasets of human brain used for Meta-AnalysisData setsPlatformReferenceTissue typeNumber of samples\
ASD;ControlBrain (male) GSE28475GPL6883 (Illumina)Chow et al. (2012)Cortex15;18 GSE28521GPL6883 (Illumina)Voineagu et al. (2011)Frontal Cortex9;14 GSE28521GPL6883 (Illumina)Voineagu et al. (2011)temporal Cortex7;11 GSE38322GPL10558 (Illumina)Ginsberg et al. (2012)Occipital Cortex4;635;49 = 84Brain (female) GSE28475GPL6883 (Illumina)Chow et al. (2012)Cortex5;4 GSE28521GPL6883 (Illumina)Voineagu et al. (2011)Frontal Cortex4;1 GSE28521GPL6883 (Illumina)Voineagu et al. (2011)Temporal Cortex3;1 Brain (other)12;6 = 18 GSE28475GPL6883 (Illumina)Chow et al. (2012)Formalin fixed Cortex1;3 GSE28521GPL6883 (Illumina)Voineagu et al. (2011)Cerebellum5;11 GSE38322GPL10558 (Illumina)Ginsberg et al. (2012)Cerebellum8;8 Table 2Datasets of mouse ASD modelData setsPlatformReferenceTissue typeNumber of samples ASD;ControlBrain GSE62594GPL13912 (Agilent)Shpyleva et al. (2014)Cerebellum8;8 GSE51612GPL7202 (Agilent)Sgadò et al. (2013)Cerebellum3;3 GSE40630GPL6246 (Affymetrix)Kong et al. (2014)Cerebellum8;8 GSE47150GPL1261 (Affymetrix)Lanz TA et al. (2013)Cortex30;4 GSE32012GPL6246 (Affymetrix)Horev G et al. (2011)Cerebellum, Cortex5;354;26 = 80 Table 3Mouse models of ASD in five datasetsMouse modelTissue typeDatasetExperimental; Control16p11.2(df/+)CortexGSE320122;316p11.2(dp/+)CortexGSE320122;3MEF2D-KOCortexGSE471503;4NLGN1-KOCortexGSE471504;4PTEN-KOCortexGSE471504;4SHANK3-KOCortexGSE471503;4Fmr1-KOCortexGSE471504;4MeCP2-KOCortexGSE471504;4MEF2A-KOCortexGSE471504;4NLGN3-KOCortexGSE471504;416p11.2(df/+)CerebellumGSE320122;316p11.2(dp/+)CerebellumGSE320123;3Fmr1-KOCerebellumGSE406305;5Tsc2+/−CerebellumGSE406303;3En2−/−CerebellumGSE516123;3BTBR T + tf/JCerebellumGSE625948;8 Table 4Data processing of all gene expression datasetsDatasetChip TypeData ProcessingR PackageHuman GSE28475IlluminaQuantile normalization and log~2~ transformationlumi GSE28521IlluminaQuantile normalization and log~2~ transformationlumi GSE28521IlluminaQuantile normalization and log~2~ transformationlumiMouse GSE62594AgilentQuantile normalization and log~2~ transformationlimma GSE51612AgilentQuantile normalization and log~2~ transformationlimma GSE40630AffymetrixRMAaffy GSE47150AffymetrixRMAaffy GSE32012AffymetrixRMAaffy

Mean gene expression values were computed for technical replicates to attain a single gene expression profile for each subject. We also conducted "Differential expression analysis" on each dataset by using *limma* R package \[[@CR27]\] and obtained *p*-values for each probe between case and control. Probes that did not map to a gene were excluded. Then, all the *p-*values for each probe were ranked, for multiple probes that mapped to a gene, only probe with the lowest *p-*values was selected. All the gene expression datasets were corrected for batch effects with the *ComBat* function \[[@CR29]\] of the R package *sva* \[[@CR30]\]. Among all the datasets, the human studies contained 17,742 genes in common for meta-analysis, whereas in the mouse models, there were 12,109 genes in common with the genes in the human studies.

Meta-analysis of gene expression data {#Sec4}
-------------------------------------

Two meta-analysis methods were applied to the normalized male cortex sample expression data \[[@CR31], [@CR32]\]. These two methods that were applied to male cortex data were completed with the wrapper function of *metaMA* \[[@CR32]\] in the R package *MAMA* \[[@CR33]\]. In brief, the first approach (effect size combination method \[[@CR32]\]) combines effect sizes from each dataset into a meta-effect size to estimate the amount of change in expression across all datasets. Datasets for each of the three human gene expression studies were generated from Illumina expression bead chips. The genes in common across studies were selected. Effect sizes for these unpaired datasets were calculated from moderated t-tests for each study, and then, these effect sizes were combined by using an explicitly random-effect model \[[@CR32]\]. The result, denoted TestStatistic, is a vector with test statistics ("combined effect size") in the meta-analysis. Then, according to the results of the test statistics, two-tailed *p-*values of the effect size combination method for each gene were computed, and Benjamini-Hochberg correction was used to correct the *p-*values for multiple hypothesis testing \[[@CR34]\].

A second approach (*P*-value combination method) that combines *P*-values from individual experiments to identify genes with a large effect size in all datasets was also used. In the *P*-value combination method, *P*-values for these unpaired datasets were calculated from moderated t-tests for each study, and then, these *P*-values were combined by using an explicitly random-effect model \[[@CR32]\]. The TestStatistic result is also a vector with test statistics ("combined *P*-values") in meta-analysis. Then, according to the results of test statistics, two-tailed *p-*values of the effect size combination method for each gene were computed, and Benjamini-Hochberg correction was used to correct the *p-*values for multiple hypothesis testing \[[@CR34]\].

Overall, *P*-value combination methods usually outperformed effect size combination approaches regarding sensitivity and gene ranking. Effect size combination methods were found to be more conservative. The ability of effect sizes to handle variance components was matched by *P*-value combination by using these moderated t-tests \[[@CR32]\].

In addition, forest plots of the human brain samples and mouse brain samples were generated with the *metacont* function of the R package *meta* \[[@CR35]\]. Random effects estimates for the meta-analyses were calculated with continuous outcome data, and the *p* value that was calculated in these forest plots described a heterogeneity test. For human brain samples, we applied the meta-analysis in the *metacont* function \[[@CR35]\] to generate three forest plots that contained an only male cortex plot, an only cerebellum plot and separate cortex plot of the male cortex, female cortex and formalin cortex samples. For mouse model brain samples, we also applied the meta-analysis to generate three separate forest plots that contained only the cortex plot and two cerebellum plots of Affymetrix chip and Agilent chip.

Design of database {#Sec5}
------------------

After completion of the meta-analysis, the portal dbMDEGA was established in R language by using the *Shiny* R package \[[@CR36]\], and it shows the calculated meta-analysis results of the genes, the corresponding forest plots and bean plots of the gene expression comparison between cases and controls. The bean plot visualizes univariate data between groups and shows data characteristics such as density curves, repeated observations and multimodal distribution. Users can access the established database online to obtain the corresponding meta-analysis results of this study.

Database content {#Sec6}
----------------

The dbMDEGA was able to integrate ASD meta-analysis results from human brain tissues and mouse models and to display diverse annotations (Fig. [1](#Fig1){ref-type="fig"}). To help users and to ensure that they obtain the results for genes in this database, in the Common Gene Data of the Index sidebar panel, a downloadable file is provided containing all the common gene symbols used in the human studies and mouse ASD models. When a user clicks the "Download" mark below Common Gene Data, a common gene symbol file can be downloaded to the user's computer. Here, the meta-analysis genes related to ASD, identified in three human studies (GSE28475, GSE28521, GSE38322), are annotated with three data panels: (i) In the Meta-summary panel, when users submit a gene, the unique meta-analysis results for the male cortex, determined through our calculations, are shown for each gene along with a forest plot showing the standardized mean difference in each of the three human ASD studies. For comparing the influence of brain regions, sex, and tissue state, this database provides an additional two separate forest plots (one for cerebellum samples and one for cortex samples, including female cortex and formalin cortex samples) to show the standardized mean difference in different parts of brain tissue and the different sexes and states. (ii) In the Human-tissue panel, statistical values of male cortex gene expression in people with ASD compared with normal individuals in each human study are displayed with a bean plot and a summary of mean, median and quartile values for cases and controls. (iii) In addition, we include a Mouse-model panel for comparison, which shows three separate forest plots (one for cortex samples and two cerebellum plots of Affymetrix chip and Agilent chip) of *DEGs* between mouse model and wild-type in 14 ASD models.Fig. 1A flow diagram for the collection, annotation and presentation of associated genes for ASD. (1) The data in this database were obtained from our meta-analysis results and gene expression datasets of human and mouse ASD studies obtained from GEO DataSets (<http://www.ncbi.nlm.nih.gov/gds>). (2) Gene entry is organized for searching in the database. (3) The developed database is presented

Utility and discussion {#Sec7}
======================

Search and display of dbMDEGA {#Sec8}
-----------------------------

User can click the "Download" button below Common Gene Data to download the common gene symbols we used in this database. The information in our database can be searched and visualized in several ways. A typical search result of our database is illustrated in Fig. [2](#Fig2){ref-type="fig"}. In this case, searching for a gene in the common gene symbols shows a list of information for this ASD-associated gene in the Web sidebar and main panel. This list contains the meta-analysis results, the candidate gene's expression in different human studies, annotated with bean plot and summary results, and the results of mouse model studies, as shown in forest plots. The list shows the following: (i) In the Meta-summary panel, the user first inputs a gene symbol or gene name into the sidebar panel and submits the query. Then, the main panel reveals not only the values of effect size, *P*-value and false discovery rate (FDR) in the meta-analysis for this gene but also a forest plot of male cortex data from three human brain studies. Additionally, we provide two additional separate forest plots (one forest plot is for only the cerebellum and another forest plot is for cortex, including female and formalin fixed cortex) (Fig. [2a](#Fig2){ref-type="fig"}). (ii) In the Human-tissue panel, the user can select a GSE number from the human ASD studies (GSE28475, GSE38322, and GSE28521) and submit a query in the sidebar. The main panel displays the query gene's expression diversity by using an intuitive bean plot of only the male cortex in ASD individuals and normal controls in the selected human ASD study. Additionally, concrete summary data of the gene's expression in cases (human ASD) and controls (human non-ASD) is provided (Fig. [2b](#Fig2){ref-type="fig"}). (iii) The Mouse-model panel also presents three separate forest plots (one for cortex samples and two cerebellum plots of Affymetrix chip and Agilent chip) of the queried gene among the 14 mouse model ASD studies, for comparison (Fig. [2c](#Fig2){ref-type="fig"}). All the data in dbMDEGA are freely available for academic users. dbMDEGA can be accessed via ([https://dbmdega.shinyapps.io/dbMDEGA/](https://dbmdega.shinyapps.io/dbMDEGA)).Fig. 2Online display of dbMDEGA search results. The example shows retrieval of a candidate gene, *ITPR1*, in dbMDEGA, (**a**) The meta-analysis results for male cortex together with three forest plots (for human male cortex samples; for human cerebellum samples; and for male, female and formalin fixed cortex) are displayed. **b** The statistical values of the candidate gene in one human dataset and a bean plot of the cases and controls are presented. **c** The candidate gene is also annotated with three forest plots of 14 mouse ASD model studies

Discussion {#Sec9}
==========

In our study, a meta-analysis was performed on current gene expression profiles of different brain tissues in human ASD studies and mouse ASD model studies; then, an open-access visualization database, dbMDEGA, was established with our meta-analysis results. dbMDEGA is the first database that displays the meta-analysis results of candidate DEGs in ASD, and it facilitates the exploration of unknown genetic causes of ASD. The corresponding results in the database are available for online searching, and may provide a reference for other researchers and follow-up studies. Furthermore, our database model could be replicated to study other disorders and establish corresponding databases of meta-analysis results.

Compared with other databases related to ASD (such as AutDB \[[@CR37]\] and SFARI \[[@CR24]\]), our database content is based on a systematic analysis of the existing gene expression datasets to indicate the overall differential expression of ASD candidate genes in different ASD studies. However, SFARI \[[@CR24]\] and AutDB \[[@CR37]\] both place emphasis on classifying and summarizing the candidate genes reported by published ASD studies. dbMDEGA can be used more intuitively to detect genetic causes of ASD. dbMDEGA can complement these two databases by providing systematic gene expression profile data on ASD, and it may help other researchers to further examine their genes of interest in ASD.

Genes contained in the visualization database dbMDEGA all have corresponding meta-analysis results and Forest plots together with bean plots, thus providing researchers with relatively more information that is intuitively understandable. For example, the reported neuronal specific splicing factor A2BP1, identified in previous ASD studies \[[@CR10], [@CR11]\], is statistically significant in dbMDEGA (TestStatistic = 2.73, *p*-value = 0.00, FDR = 0.07). In addition, compared with other existing meta-analysis reports, the visualization database dbMDEGA based on meta-analysis results has been consistent and inclusive. For instance, significant cellular respiration genes such as ATP5O (Meta *P*-value = 1.83 × 10--5), SLC25A12 (Meta *P*-value = 2.98 × 10--4), and COX5B (Meta *P*-value = 5.37 × 10--4) have been identified in other meta-analysis results \[[@CR20]\]; in dbMDEGA, these genes also have a corresponding presentation (TestStatistic = 2.92, *p*-value = 0.00, FDR = 0.05; TestStatistic = 2.40, *p*-value = 0.01, FDR = 0.09; TestStatistic =2.11, *p*-value = 0.02, FDR = 0.13).

Heterogeneity between tissue samples and different studies is a considerable problem in expression profile analysis. Observations in diverse tissues such as the difference between blood and brain \[[@CR19]\] and the difference among different regions of the brain \[[@CR11]\] may be inconsistent and have not been fully explored in other meta-analysis studies of ASD. In our studies, only brain samples were used to perform the meta-analysis. For ASD studies, blood samples are easier to collect, but changes in the gene profile in the blood may not be observed in the brain, owing to tissue specificity \[[@CR19], [@CR22]\]. Hence, it is crucial to perform meta-analyses based on human brain samples for ASD studies.

Moreover, Voineagu et al. \[[@CR11]\] have proposed gene expression differences between the cerebellum and cortex, and have indicated that gene expression changes associated with autism are more pronounced in the cerebral cortex. Ch'ng et al. \[[@CR20]\] have also separated the cerebellum tissue and used the cortex of ASD cases and controls to conduct a meta-analysis. However, the verdict on gene expression changes between the cerebellum and cortex remains unclear. To intuitively show the difference among different regions of ASD in our database, we applied meta-analysis to obtain two separate forest plots: an only male cortex plot and an only cerebellum plot. Data from mouse models have been applied to the meta-analysis to obtain three forest plots that contain an only cortex plot and two cerebellum plots of Affymetrix chip and Agilent chip separately. To account for differences in sex and tissue state, we also applied the meta-analysis to generate one forest plot that contains a cortex plot of separate male cortex, female cortex and formalin cortex.

Perspective {#Sec10}
-----------

The occurrence of ASD, a severe neurodevelopmental disease, has increased significantly in recent years. Accumulating evidence suggests that genetic changes contribute to ASD, and studies reporting candidate genes associated with ASD are quickly accumulating. Here, we developed dbMDEGA to facilitate the discovery of candidate genes associated with ASD, on the basis of meta-analyses. In the future, when more ASD studies have been performed, we will update dbMDEGA accordingly.

Conclusions {#Sec11}
===========

dbMDEGA is a publicly available web-portal and new analytical tool that allows for searchable meta-analysis results based on the current reported brain gene expression ASD datasets. This database is designed to share our meta-analysis results and provides valuable assistance in the discovery of *DEGs* and the molecular pathogenicity of ASD. Moreover, our database model could be replicated to study other disorders.
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================

 {#Sec12}

Additional file 1: Table S1.Brain samples of cortex included in the meta-analysis. (DOC 93 kb) Additional file 2: Table S2.Brain samples of cerebellum included in the meta-analysis. (DOC 52 kb)
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